2017

  1. Dopeso H, Rodrigues P, Bilic J, Bazzocco S, Cartón-García F, Macaya I, de Marcondes PG, Anguita E, Masanas M, Jiménez-Flores LM, Martínez-Barriocanal Á, Nieto R, Segura MF, Schwartz S Jr, Mariadason JM, Arango D. Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.. Br J Cancer. 2018;118 (1):106-116. doi: 10.1038/bjc.2017.420. PubMed PMID:29206819 PubMed Central PMC5765235.

  2. Alonso-Molero J, González-Donquiles C, Palazuelos C, Fernández-Villa T, Ramos E, Pollán M, Aragonés N, Llorca J, Henar Alonso M, Tardón A, Amiano P, Moleon JJJ, Pérez RP, Capelo R, Molina AJ, Acebo IG, Guevara M, Perez-Gomez B, Lope V, Huerta JM, Castaño-Vinyals G, Kogevinas M, Moreno V, Martín V. The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis.. BMC Med Genet. 2017;18 (1):122. doi: 10.1186/s12881-017-0485-5. PubMed PMID:29084532 PubMed Central PMC5661920.

  3. Barontini J, Antinucci M, Tofanelli S, Cammalleri M, Dal Monte M, Gemignani F, Vodicka P, Marangoni R, Vodickova L, Kupcinskas J, Vymetalkova V, Forsti A, Canzian F, Stein A, Moreno V, Mastrodonato N, Tavano F, Panza A, Barale R, Landi S, Campa D. Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.. BMC Gastroenterol. 2017;17 (1):104. doi: 10.1186/s12876-017-0659-9. PubMed PMID:28915899 PubMed Central PMC5603047.

  4. Fernández de Larrea-Baz N, Pérez-Gómez B, Michel A, Romero B, Lope V, Pawlita M, Fernández-Villa T, Moreno V, Martín V, Willhauck-Fleckenstein M, López-Abente G, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Santibáñez M, Peiró R, Jiménez-Moleón JJ, Navarro C, Castaño-Vinyals G, Kogevinas M, Pollán M, de Sanjosé S, Del Campo R, Waterboer T, Aragonés N. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.. Cancer Epidemiol. 2017;50 (Pt A):76-84. doi: 10.1016/j.canep.2017.08.002. PubMed PMID:28888185 .

  5. Gómez-Acebo I, Dierssen-Sotos T, Fernandez-Navarro P, Palazuelos C, Moreno V, Aragonés N, Castaño-Vinyals G, Jiménez-Monleón JJ, Ruiz-Cerdá JL, Pérez-Gómez B, Ruiz-Dominguez JM, Molero JA, Pollán M, Kogevinas M, Llorca J. Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study.. Sci Rep. 2017;7 (1):8994. doi: 10.1038/s41598-017-09386-9. PubMed PMID:28827750 PubMed Central PMC5566549.

  6. Feng YA, Cho K, Lindstrom S, Kraft P, Cormack J, IGAP Consortium, Colorectal Transdisciplinary Study (CORECT), Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE), Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), Transdisciplinary Research in Cancer of the Lung (TRICL), Liang L, Driver JA. Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics.. Hum Genet. 2017;136 (10):1341-1351. doi: 10.1007/s00439-017-1831-6. PubMed PMID:28780673 PubMed Central PMC5693762.

  7. Castelló A, Boldo E, Pérez-Gómez B, Lope V, Altzibar JM, Martín V, Castaño-Vinyals G, Guevara M, Dierssen-Sotos T, Tardón A, Moreno V, Puig-Vives M, Llorens-Ivorra C, Alguacil J, Gómez-Acebo I, Castilla J, Gràcia-Lavedán E, Dávila-Batista V, Kogevinas M, Aragonés N, Amiano P, Pollán M. Adherence to the Western, Prudent and Mediterranean dietary patterns and breast cancer risk: MCC-Spain study.. Maturitas. 2017;103 :8-15. doi: 10.1016/j.maturitas.2017.06.020. PubMed PMID:28778338 .

  8. Fernández-de-Larrea N, Michel A, Romero B, Butt J, Pawlita M, Pérez-Gómez B, Castaño-Vinyals G, Moreno V, Martín V, Amiano P, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Clofent J, Alguacil J, Huerta JM, Jiménez-Moleón JJ, Barricarte A, Molinuevo A, Fernández-Villa T, Casabonne D, Sierra Á, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.. Helicobacter. 2017;22 (5):. doi: 10.1111/hel.12401. PubMed PMID:28737284 .

  9. Ardevol A, Ibañez-Sanz G, Profitos J, Aracil C, Castellvi JM, Alvarado E, Cachero A, Horta D, Miñana J, Gomez-Pastrana B, Pavel O, Dueñas E, Casas M, Planella M, Castellote J, Villanueva C. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.. Hepatology. 2018;67 (4):1458-1471. doi: 10.1002/hep.29370. PubMed PMID:28714072 .

  10. Alonso MHAussó SLopez-Doriga ACordero DGuinó ESolé X, Barenys M, de Oca J, Capella G, Salazar R, Sanz-Pamplona RMoreno VComprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.. Br J Cancer. 2017;117 (3):421-431. doi: 10.1038/bjc.2017.208. PubMed PMID:28683472 PubMed Central PMC5537504.

  11. Huerta JM, Chirlaque MD, Molina AJ, Amiano P, Martín V, Fernández-Villa T, Pérez-Gómez B, Moreno V, Burgui R, Gómez-Acebo I, Ramos-Lora M, Fernández-Tardón G, Peiró R, Olmedo-Requena R, Pollán M, Kogevinas M, Castaño-Vinyals G, Aragonés N, Navarro. Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study.. PLoS One. 2017;12 (7):e0179731. doi: 10.1371/journal.pone.0179731. PubMed PMID:28683070 PubMed Central PMC5500262.

  12. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in and Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis.. Clin Cancer Res. 2017;23 (19):5936-5947. doi: 10.1158/1078-0432.CCR-17-0821. PubMed PMID:28645942 PubMed Central PMC5626604.

  13. Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga AMoreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R. Optimization of Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.. Mol Cancer Ther. 2017;16 (9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. PubMed PMID:28626084 .

  14. Fernández de Larrea-Baz N, Michel A, Romero B, Pérez-Gómez B, Moreno V, Martín V, Dierssen-Sotos T, Jiménez-Moleón JJ, Castilla J, Tardón A, Ruiz I, Peiró R, Tejada A, Chirlaque MD, Butt JA, Olmedo-Requena R, Gómez-Acebo I, Linares P, Boldo E, Castells A, Pawlita M, Castaño-Vinyals G, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N. Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain.. Front Microbiol. 2017;8 :888. doi: 10.3389/fmicb.2017.00888. PubMed PMID:28611733 PubMed Central PMC5447227.

  15. Romaguera D, Gracia-Lavedan E, Molinuevo A, de Batlle J, Mendez M, Moreno VVidal C, Castelló A, Pérez-Gómez B, Martín V, Molina AJ, Dávila-Batista V, Dierssen-Sotos T, Gómez-Acebo I, Llorca J, Guevara M, Castilla J, Urtiaga C, Llorens-Ivorra C, Fernández-Tardón G, Tardón A, Lorca JA, Marcos-Gragera R, Huerta JM, Olmedo-Requena R, Jimenez-Moleon JJ, Altzibar J, de Sanjosé S, Pollán M, Aragonés N, Castaño-Vinyals G, Kogevinas M, Amiano P. Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.. Int J Cancer. 2017;141 (1):83-93. doi: 10.1002/ijc.30722. PubMed PMID:28380695 .

  16. Mateo-Lozano S, Bazzocco S, Rodrigues P, Mazzolini R, Andretta E, Dopeso H, Fernández Y, Del Llano E, Bilic J, Suárez-López L, Macaya I, Cartón-García F, Nieto R, Jimenez-Flores LM, de Marcondes PG, Nuñez Y, Afonso E, Cacci K, Hernández-Losa J, Landolfi S, Abasolo I, Ramón Y Cajal S, Mariadason JM, Schwartz S Jr, Matsui T, Arango D. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.. Sci Rep. 2017;7 :43702. doi: 10.1038/srep43702. PubMed PMID:28262839 PubMed Central PMC5337985.

  17. Papantoniou K, Castaño-Vinyals G, Espinosa A, Turner MC, Alonso-Aguado MH, Martin V, Aragonés N, Pérez-Gómez B, Pozo BM, Gómez-Acebo I, Ardanaz E, Altzibar JM, Peiro R, Tardon A, Lorca JA, Chirlaque MD, García-Palomo A, Jimenez-Moleon JJ, Dierssen T, Ederra M, Amiano P, Pollan M, Moreno V, Kogevinas M. Shift work and colorectal cancer risk in the MCC-Spain case-control study.. Scand J Work Environ Health. 2017;43 (3):250-259. doi: 10.5271/sjweh.3626. PubMed PMID:28251241 .

  18. Ibáñez-Sanz GDíez-Villanueva AAlonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó EBinefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno VRisk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.. Sci Rep. 2017;7 :43263. doi: 10.1038/srep43263. PubMed PMID:28233817 PubMed Central PMC5324108.

  19. Andretta E, Cartón-García F, Martínez-Barriocanal Á, de Marcondes PG, Jimenez-Flores LM, Macaya I, Bazzocco S, Bilic J, Rodrigues P, Nieto R, Landolfi S, Ramon Y Cajal S, Schwartz S, Brown A, Dopeso H, Arango D. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.. Sci Rep. 2017;7 :41576. doi: 10.1038/srep41576. PubMed PMID:28169277 PubMed Central PMC5294649.

  20. Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM, OCAC, CORECT, TRICL, ELLIPSE, DRIVE, and GAME-ON consortia. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.. Cancer Epidemiol Biomarkers Prev. 2017;26 (6):816-825. doi: 10.1158/1055-9965.EPI-16-0728. PubMed PMID:28115406 PubMed Central PMC6054308.

  21. Piulats JM, Guerra E, Gil-Martín M, Roman-Canal B, Gatius S, Sanz-Pamplona R, Velasco A, Vidal A, Matias-Guiu X. Molecular approaches for classifying endometrial carcinoma.. Gynecol Oncol. 2017;145 (1):200-207. doi: 10.1016/j.ygyno.2016.12.015. PubMed PMID:28040204 .

  22. Macauda A, Calvetti D, Maccari G, Hemminki K, Försti A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martinez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudziński M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jażdżewska E, Raźny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stępień A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet-Loiseau H, Lesueur F, Grząśko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F. Identification of miRSNPs associated with the risk of multiple myeloma.. Int J Cancer. 2017;140 (3):526-534. doi: 10.1002/ijc.30465. PubMed PMID:27718532 .

  23. Ibañez-Sanz GGarcia MMilà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno VFalse-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.. Eur J Cancer Prev. 2017;26 (5):365-367. doi: 10.1097/CEJ.0000000000000281. PubMed PMID:27433880 .

  24. Villanueva CM, Gracia-Lavedan E, Bosetti C, Righi E, Molina AJ, Martín V, Boldo E, Aragonés N, Perez-Gomez B, Pollan M, Acebo IG, Altzibar JM, Zabala AJ, Ardanaz E, Peiró R, Tardón A, Chirlaque MD, Tavani A, Polesel J, Serraino D, Pisa F, Castaño-Vinyals G, Espinosa A, Espejo-Herrera N, Palau M, Moreno V, La Vecchia C, Aggazzotti G, Nieuwenhuijsen MJ, Kogevinas M. Colorectal Cancer and Long-Term Exposure to Trihalomethanes in Drinking Water: A Multicenter Case-Control Study in Spain and Italy.. Environ Health Perspect. 2017;125 (1):56-65. doi: 10.1289/EHP155. PubMed PMID:27383820 PubMed Central PMC5226692.